- Home
- Companies
- switzerland
- in vitro
Refine by
In Vitro Technology Serving Switzerland
33 companies found
Technologybased inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
Technologybased in
JOANNEUM RESEARCH Forschungsgesellschaft mbH develops solutions and technologies for businesses and industries across a wide range of sectors and conducts top-level research at an international level. With a focus on applied research and technology ...
The evaluation of wound dressings and medical devices (e.g. skin substitutes) is of great importance to ensure their effectiveness and safety. We can also determine the "mode of action" of these materials. ...
Technologybased inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...
Technologybased inWoburn, MASSACHUSETTS (USA)
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians and payors. Founded in 2014, its vision is to provide the first credible replacement to metal implants in the multibillion-dollar ...
Bio-Integrative OSSIOfiber® Compression Screw and Sterile, Disposable Instrumentation. Superior Fixation meets Better Bone Healing. The Patient Experience is Yours to Transform. Our Compression Screws deliver superior performance to conventional ...
Technologybased inWadenswil, SWITZERLAND
3Brain is the world’s first company to connect cells with sophisticated silicon chips in cell culture plates. Stemming from our passion for technology and scientific progress, our co-founders have worked for more than 15 years on CMOS-powered ...
BioCAM DupleX is a state-of-the-art, high-resolution microelectrode array (also known as multielectrode array) platform for powerful in vitro functional imaging. Its bidirectional electrodes make it possible to simultaneously ...
Technologybased inPréverenges, SWITZERLAND
Founded in 2016 by a group of experienced engineers and bio-informaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure ...
GenomSys Variant Analyzer is a CE-marked platform natively operating on MPEG-G genomic data format that enables accurate variants identification, annotation, and interpretation (SNVs, indels, CNVs). Based on state-of-the-art pipelines and leveraging ...
Technologybased inLYON, FRANCE
Founded in December 2013, Adjuvatis is specialized in the development, manufacturing and formulation of a safe-by-design delivery system, called i-Particles®. Based on fully metabolizable ans biocompatible particles, this technology was initially ...
Develop your own formulation, unlock your product full potential. Formulating with i-Particles® is the answer to solubilisation, stability, toxicity and performance issues. From design to customer support, Adjuvatis is driven by quality ...
Technologybased inRahway, NEW JERSEY (USA)
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of ...
BCG VACCINE for percutaneous use is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bov/s.{1} The TICE® strain used in this BCG VACCINE preparation was developed at the University of ...
Technologybased inBirkenfeld, GERMANY
STRATEC is a world leading partner for fully automated analyzer systems, software and smart consumables. Building on an unparalleled breadth of technology and the expertise gained in more than forty years of automating laboratory processes, STRATEC ...
STRATEC is a reliable partner and one-stop provider of end-to-end automation solutions in the fields of in-vitro diagnostics and life sciences. Our capabilities, technology and processes span the entire value chain of new product ...
Technologybased inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Horizon carrier screening helps couples determine the risk of passing on serious genetic conditions to their child. It can be performed either preconception (ideally) or during ...
Technologybased inSchlieren, SWITZERLAND
Redbiotec is a private biotech company in Zurich-Schlieren. Founded in 2006 as a spin-off of ETH Zürich, the company has won several awards, including the renowned W.A. de Vigier Award. In 2015, Pfizer acquired Redvax (a Redbiotec spin-off) for its ...
Redbiotec specializes in developing high-quality vaccines to fight difficult diseases. After successfully spinning out the CMV vaccine program that was acquired by Pfizer, Redbiotec is currently developing HSV-2 therapeutic vaccine ...
Technologybased inSão Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
The Celluris’ novel solution, named RfuCAR, was engineering in order to respond some challenges addressed by clinical trials around the world. RfuCAR is a bispecific in tandem receptor CAR, that is composed by an antigen binding domain and ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
DSP-0390 is an emopamil-binding protein (EBP) inhibitor. EBP is an endoplasmic reticulum membrane protein involved in cholesterol biosynthesis.47 When functional, EBP mediates de novo cholesterol synthesis for cell membrane structure and signaling, ...
Technologybased inNangang Distric, TAIWAN
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...
Studies by X. Yao et al and S. Perinel et al suggest that HCQ can prevent the acidification of intracellular organelles, inhibit lysosomal release of viral genome and interfere with the glycosylation of the angiotensin-converting enzyme-2 (ACE2) ...
Technologybased inViken, SWEDEN
TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...
Cell therapies are associated with graft loss. It involves activation of the complement and coagulation cascades when cells come into contact with blood, ultimately resulting in cell death. IBSOLVMIR is an infusion product that inhibits IBMIR and ...
Technologybased inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
Technologybased inVerona, ITALY
At Sibylla Biotech, we face the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs. Born out of a scientific challenge, the PPI-FIT protocol (Pharmacological Protein Inactivation by Folding ...
The PPI-FIT (Pharmacological Protein Inactivation by Folding Intermediate Targeting) technology, of which Sibylla is the exclusive licensee, is a paradigm shift in rational drug design. The basic task of drug design is to find a small molecule able ...
Technologybased inBuffalo Grove, ILLINOIS (USA)
BIOLIFE4D is a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant – lifesaving technology that gives patients the gift of time. With ...
For years scientists and engineers have been using 3D printers to create objects out of metals and plastics. The 3D printing industry has become so big, in fact, that over the next few years its projected worth is expected to top $30 ...
Technologybased inJena, GERMANY
As a biotechnology company, we at oncgnostics GmbH have been working on the diagnosis of cancer on a molecular biological basis since 2012. Our cancer tests are used in early cancer detection and diagnosis.Our first product, GynTect®, was developed ...
Technologybased inGaithersburg, MARYLAND (USA)
ZyMot Fertility, Inc. (a subsidiary of DxNow, Inc.) is commercializing worldwide the ZyMot Sperm Separation Devices, first-of-their-kind devices for use in assisted reproductive technology (ART) procedures. We’re a Maryland-based and ...